Akshay Vaishnaw Insider Trading $ALNY ALNYLAM PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Akshay Vaishnaw.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Akshay Vaishnaw. Akshay Vaishnaw is EVP, Chief Medical Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and EVP, R&D in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and EVP, R&D, CMO in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and President, R&D in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and SVP, R&D in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in Editas Medicine, Inc. ($EDIT) and Director in Scholar Rock Holding Corp ($SRRK).
Akshay Vaishnaw in ALNYLAM PHARMACEUTICALS, INC.
Trading Symbol: ALNYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Akshay Vaishnaw: President, R&D, SVP, R&D, EVP, R&D, CMO, EVP, Chief Medical Officer
Holdings: 22,908 shares
Current Value: $926,858
Latest Transaction: Apr 21 2021
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Akshay Vaishnaw in ALNYLAM PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, EDIT, SRRK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 138.48 | 107 | 14,817 | 14,119 | 14.2 K to 14.1 K (-0.75 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 137.60 | 530 | 72,928 | 14,226 | 14.8 K to 14.2 K (-3.59 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 136.84 | 1,892 | 258,901 | 14,756 | 16.6 K to 14.8 K (-11.36 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 135.41 | 203 | 27,488 | 16,648 | 16.9 K to 16.6 K (-1.20 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 134.56 | 85 | 11,438 | 16,851 | 16.9 K to 16.9 K (-0.50 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 131.75 | 2,266 | 298,546 | 16,936 | 19.2 K to 16.9 K (-11.80 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.02 | 417 | 58,388 | 19,202 | 19.6 K to 19.2 K (-2.13 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 138.64 | 622 | 86,234 | 19,619 | 20.2 K to 19.6 K (-3.07 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 137.60 | 989 | 136,086 | 20,241 | 21.2 K to 20.2 K (-4.66 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 136.76 | 1,678 | 229,483 | 21,230 | 22.9 K to 21.2 K (-7.32 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 5,083 | 0 | 22,908 | 17.8 K to 22.9 K (+28.52 %) |
Feb 26 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 151.59 | 28,800 | 4,365,792 | 28,800 | |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 119.13 | 8,334 | 992,829 | 25,000 | |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 152.53 | 92 | 14,033 | 17,825 | 17.9 K to 17.8 K (-0.51 %) |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 156.00 | 1,618 | 252,408 | 17,917 | 19.5 K to 17.9 K (-8.28 %) |
Feb 16 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 5,416 | 0 | 19,535 | 14.1 K to 19.5 K (+38.36 %) |
Oct 01 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 971 | 40,996 | 3,338 | |
Oct 01 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.00 | 971 | 135,940 | 14,119 | 15.1 K to 14.1 K (-6.43 %) |
Oct 01 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 971 | 40,996 | 15,090 | 14.1 K to 15.1 K (+6.88 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 970 | 40,953 | 4,309 | |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 152.97 | 195 | 29,829 | 14,119 | 14.3 K to 14.1 K (-1.36 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 152.22 | 334 | 50,841 | 14,314 | 14.6 K to 14.3 K (-2.28 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 150.34 | 180 | 27,061 | 14,648 | 14.8 K to 14.6 K (-1.21 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 149.09 | 83 | 12,374 | 14,828 | 14.9 K to 14.8 K (-0.56 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 148.48 | 178 | 26,429 | 14,911 | 15.1 K to 14.9 K (-1.18 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 970 | 40,953 | 15,089 | 14.1 K to 15.1 K (+6.87 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 971 | 40,996 | 5,279 | |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 21,000 | 886,620 | 0 | |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.00 | 21,971 | 3,075,940 | 14,119 | 36.1 K to 14.1 K (-60.88 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 971 | 40,996 | 36,090 | 35.1 K to 36.1 K (+2.76 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 21,000 | 886,620 | 35,119 | 14.1 K to 35.1 K (+148.74 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 106.52 | 98 | 10,439 | 14,119 | 14.2 K to 14.1 K (-0.69 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 104.75 | 2,415 | 252,971 | 14,217 | 16.6 K to 14.2 K (-14.52 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 5,417 | 0 | 16,632 | 11.2 K to 16.6 K (+48.30 %) |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 118.05 | 27,623 | 3,260,895 | 27,623 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 18,750 | 791,625 | 6,250 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 4,000 | 168,880 | 21,000 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 125.00 | 23,708 | 2,963,500 | 11,215 | 34.9 K to 11.2 K (-67.89 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 4,000 | 168,880 | 34,923 | 30.9 K to 34.9 K (+12.94 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 18,750 | 791,625 | 30,923 | 12.2 K to 30.9 K (+154.03 %) |
Dec 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 119.13 | 8,333 | 992,710 | 16,666 | |
Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 119.13 | 8,333 | 992,710 | 8,333 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 25,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 30,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 48 | 0 | 515 | 467 to 515 (+10.28 %) |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 18,750 | |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 51 | 0 | 467 | 416 to 467 (+12.26 %) |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 21 | 0 | 416 | 395 to 416 (+5.32 %) |
Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 85.00 | 32,500 | 2,762,500 | 32,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 12,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 22,500 | |
Aug 23 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 15,000 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 96.45 | 11,707 | 1,129,140 | 35,125 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 63.00 | 10,832 | 682,416 | 32,500 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 29 | 0 | 395 | 366 to 395 (+7.92 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 28 | 0 | 366 | 338 to 366 (+8.28 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 90.95 | 766 | 69,668 | 12,173 | 12.9 K to 12.2 K (-5.92 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 1,724 | 0 | 12,939 | 11.2 K to 12.9 K (+15.37 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 18.66 | 44,641 | 833,001 | 0 | |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 16.43 | 38,913 | 639,341 | 0 | |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 7.10 | 5,000 | 35,500 | 0 | |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 145.27 | 6,380 | 926,823 | 11,215 | 17.6 K to 11.2 K (-36.26 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 144.53 | 20,172 | 2,915,459 | 17,595 | 37.8 K to 17.6 K (-53.41 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 143.46 | 19,213 | 2,756,297 | 37,767 | 57 K to 37.8 K (-33.72 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 142.57 | 21,336 | 3,041,874 | 56,980 | 78.3 K to 57 K (-27.24 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 141.69 | 15,000 | 2,125,350 | 78,316 | 93.3 K to 78.3 K (-16.07 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.45 | 6,453 | 906,324 | 93,316 | 99.8 K to 93.3 K (-6.47 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 7.10 | 5,000 | 35,500 | 99,769 | 94.8 K to 99.8 K (+5.28 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 16.43 | 38,913 | 639,341 | 94,769 | 55.9 K to 94.8 K (+69.67 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 18.66 | 44,641 | 833,001 | 55,856 | 11.2 K to 55.9 K (+398.05 %) |
Mar 05 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 119.13 | 25,000 | 2,978,250 | 25,000 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 6,250 | |
Dec 21 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Gift | G | 0.00 | 320 | 0 | 11,215 | 11.5 K to 11.2 K (-2.77 %) |
Nov 08 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 7,500 | |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 33,666 | 718,769 | 0 | |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 122.79 | 3,693 | 453,463 | 11,535 | 15.2 K to 11.5 K (-24.25 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 121.69 | 17,755 | 2,160,606 | 15,228 | 33 K to 15.2 K (-53.83 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 120.78 | 11,418 | 1,379,066 | 32,983 | 44.4 K to 33 K (-25.72 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 119.79 | 800 | 95,832 | 44,401 | 45.2 K to 44.4 K (-1.77 %) |
Nov 01 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 33,666 | 718,769 | 45,201 | 11.5 K to 45.2 K (+291.86 %) |
Sep 22 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 63.00 | 10,834 | 682,542 | 10,834 | |
Jul 11 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | A | 96.45 | 11,709 | 1,129,333 | 23,418 | |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 328 | 7,003 | 33,666 | |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 18.66 | 1,340 | 25,004 | 44,641 | |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Payment of Exercise | F | 74.31 | 430 | 31,953 | 11,535 | 12 K to 11.5 K (-3.59 %) |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 18.66 | 1,340 | 25,004 | 11,965 | 10.6 K to 12 K (+12.61 %) |
Jun 15 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 328 | 7,003 | 10,625 | 10.3 K to 10.6 K (+3.19 %) |
May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 11,000 | 234,850 | 33,994 | |
May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Sell | S | 75.00 | 11,000 | 825,000 | 10,297 | 21.3 K to 10.3 K (-51.65 %) |
May 25 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 11,000 | 234,850 | 21,297 | 10.3 K to 21.3 K (+106.83 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Option Exercise | M | 31.39 | 32,750 | 1,028,023 | 0 | |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Option Exercise | M | 21.35 | 11,000 | 234,850 | 44,994 | |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Sell | S | 65.00 | 11,000 | 715,000 | 10,297 | 21.3 K to 10.3 K (-51.65 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Buy | M | 21.35 | 11,000 | 234,850 | 21,297 | 10.3 K to 21.3 K (+106.83 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Sell | S | 65.00 | 32,750 | 2,128,750 | 10,297 | 43 K to 10.3 K (-76.08 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Buy | M | 31.39 | 32,750 | 1,028,023 | 43,047 | 10.3 K to 43 K (+318.05 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 4,356 | 93,001 | 55,994 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 18.66 | 4,019 | 74,995 | 45,981 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 16.43 | 1,172 | 19,256 | 38,913 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Payment of Exercise | F | 37.44 | 5,000 | 187,200 | 10,297 | 15.3 K to 10.3 K (-32.69 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 4,356 | 93,001 | 15,297 | 10.9 K to 15.3 K (+39.81 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 18.66 | 4,019 | 74,995 | 10,941 | 6.9 K to 10.9 K (+58.06 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 16.43 | 1,172 | 19,256 | 6,922 | 5.8 K to 6.9 K (+20.38 %) |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 22.75 | 29,165 | 663,504 | 0 | |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 46.14 | 1,500 | 69,208 | 5,750 | 7.3 K to 5.8 K (-20.69 %) |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 45.55 | 13,297 | 605,662 | 7,250 | 20.5 K to 7.3 K (-64.72 %) |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 44.34 | 14,368 | 637,127 | 20,547 | 34.9 K to 20.5 K (-41.15 %) |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 22.75 | 29,165 | 663,504 | 34,915 | 5.8 K to 34.9 K (+507.22 %) |
Feb 25 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 94.14 | 10,000 | 941,400 | 10,000 | |
Feb 03 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 96.45 | 11,709 | 1,129,333 | 11,709 | |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 88.95 | 30,000 | 2,668,500 | 30,000 | |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 22.75 | 835 | 18,996 | 29,165 | |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 16.43 | 4,915 | 80,753 | 40,085 | |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 16.43 | 4,915 | 80,753 | 5,750 | 835 to 5.8 K (+588.62 %) |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 22.75 | 835 | 18,996 | 835 | 0 to 835 |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 9.30 | 6,250 | 58,125 | 0 | |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 7.10 | 2,500 | 17,750 | 5,000 | |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 131.00 | 350 | 45,850 | 0 | 350 to 0 (-100.00 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 130.06 | 1,800 | 234,100 | 350 | 2.2 K to 350 (-83.72 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 128.79 | 2,667 | 343,479 | 2,150 | 4.8 K to 2.2 K (-55.37 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 128.10 | 3,933 | 503,811 | 4,817 | 8.8 K to 4.8 K (-44.95 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 7.10 | 2,500 | 17,750 | 8,750 | 6.3 K to 8.8 K (+40.00 %) |
Jun 18 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 9.30 | 6,250 | 58,125 | 6,250 | 0 to 6.3 K |
May 05 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 96.45 | 35,125 | 3,387,806 | 35,125 | |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 9.30 | 6,250 | 58,125 | 6,250 | |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 7.10 | 2,500 | 17,750 | 7,500 | |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 119.38 | 644 | 76,881 | 0 | 644 to 0 (-100.00 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 118.16 | 1,000 | 118,160 | 644 | 1.6 K to 644 (-60.83 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 117.35 | 2,080 | 244,088 | 1,644 | 3.7 K to 1.6 K (-55.85 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 116.34 | 3,802 | 442,325 | 3,724 | 7.5 K to 3.7 K (-50.52 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 115.29 | 1,224 | 141,115 | 7,526 | 8.8 K to 7.5 K (-13.99 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 7.10 | 2,500 | 17,750 | 8,750 | 6.3 K to 8.8 K (+40.00 %) |
Mar 19 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 9.30 | 6,250 | 58,125 | 6,250 | 0 to 6.3 K |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,250 | 58,125 | 25,001 | |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.14 | 1,875 | 17,138 | 3,750 | |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 15,000 | |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 69.97 | 8,127 | 568,620 | 0 | 8.1 K to 0 (-100.00 %) |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 69.33 | 2,498 | 173,178 | 8,127 | 10.6 K to 8.1 K (-23.51 %) |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,250 | 58,125 | 10,625 | 4.4 K to 10.6 K (+142.86 %) |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 2,500 | 17,750 | 4,375 | 1.9 K to 4.4 K (+133.33 %) |
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.14 | 1,875 | 17,138 | 1,875 | 0 to 1.9 K |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,250 | 58,125 | 50,000 | |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.14 | 3,750 | 34,275 | 11,250 | |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 5,000 | 35,500 | 25,000 | |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 31.75 | 100 | 3,175 | 12,588 | 12.7 K to 12.6 K (-0.79 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 31.07 | 4,900 | 152,249 | 12,688 | 17.6 K to 12.7 K (-27.86 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 5,000 | 35,500 | 17,588 | 12.6 K to 17.6 K (+39.72 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 31.07 | 6,250 | 194,196 | 12,588 | 18.8 K to 12.6 K (-33.18 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,250 | 58,125 | 18,838 | 12.6 K to 18.8 K (+49.65 %) |